Financial Network Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.3K Hold
33
– – 0.01% 490
2026
Q2
$11.9K Sell
33
-7
-18% -$2.14K 0.01% 465
2026
Q1
$10K Hold
40
– – 0.01% 465
2025
Q4
$11K Hold
40
– – 0.01% 456
2025
Q3
$10.5K Hold
40
– – 0.01% 449
2025
Q2
$8.75K Sell
40
-36
-47% -$7.7K 0.01% 457
2025
Q1
$17K Buy
76
+47
+162% +$13K 0.02% 355
2024
Q4
$9.5K Sell
29
-102
-78% -$32.1K 0.02% 309
2024
Q3
$39.3K Sell
131
-11
-8% -$3.37K 0.03% 302
2024
Q2
$46.3K Buy
+142
New +$50.2K 0.03% 318

Other funds holding WST

Financial Network Wealth Advisors's WST Position: Q3 2026 in Review

Financial Network Wealth Advisors held its West Pharmaceutical (WST) position steady in Q3 2026 at 33 shares worth $12.3K. The position accounts for 0.01% of the portfolio, ranked #490.

Financial Network Wealth Advisors first reported a position in WST in Q2 2024 and has held it in 10 quarters since. The position peaked at $46.3K in Q2 2024. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Financial Network Wealth Advisors held 33 shares of West Pharmaceutical worth $12.3K as of Q3 2026.
  • Financial Network Wealth Advisors left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.01% of Financial Network Wealth Advisors's portfolio in Q3 2026, its #490 holding.
  • Financial Network Wealth Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 10 quarters since.
  • Financial Network Wealth Advisors's West Pharmaceutical position peaked at $46.3K in Q2 2024.
  • 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.